Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Record of Telephone Con., January 26, 2011 - Adenovirus 

Submission Type: BLA Submission ID: 125296/0 Office: OVRR

Product: Adenovirus Vaccine Live Oral Type 4 and Type 7

Applicant: Teva Women's Health, Inc.

Telecon Date/Time: 26-Jan-2011 04:07 PM Initiated by FDA? Yes

Communication Category: Information Request

Author: Helen Gemignani

Telecon Summary: Request for Categorical Exclusion

FDAParticipants: Helen Gemignani

Non-FDA Participants: Valerie Mulligan

Telecon Body: Please submit a formal request for Categorical Exclusion from an Environmental Assessment (in Section 1.12.14 Environmental Analysis) for your product under 21 CFR 25.31.

Page Last Updated: 09/25/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English